Avicanna Inc. announced that it has expanded the scope and duration of its research and collaboration agreement with Dr. Christine Allen's research group at the University of Toronto. Additionally, Dr. Allen has stepped down as Avicanna's Chief Scientific Officer, having accepted a prominent role with the University of Toronto, however, Dr. Allen will increase her involvement in Avicanna's pharmaceutical development and optimization through the expanded collaboration between Avicanna and Dr. Allen's research group. Dr. Allen has stepped down as the company's Chief Scientific Officer but will continue to lead Avicanna's pharmaceutical development efforts through the extended research & collaboration agreement.